Alfonso Calvo

Alfonso Calvo

UNVERIFIED PROFILE

Are you Alfonso Calvo?   Register this Author

Register author
Alfonso Calvo

Alfonso Calvo

Publications by authors named "Alfonso Calvo"

Are you Alfonso Calvo?   Register this Author

90Publications

1701Reads

14Profile Views

Identification of c.1531C>T Pathogenic Variant in the Gene as a Novel Germline Mutation of Hereditary Diffuse Gastric Cancer.

Int J Mol Sci 2019 Oct 9;20(20). Epub 2019 Oct 9.

Advanced Center for Chronic Diseases (ACCDiS), Pontificia Universidad Católica de Chile, Santiago 8330024, Chile.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms20204980DOI Listing
October 2019

Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery.

Cancer Lett 2019 Jul 21;453:21-33. Epub 2019 Mar 21.

IDISNA and Program in Solid Tumors, Center for Applied Medical Research (CIMA), University of Navarra, 31008, Pamplona, Navarra, Spain; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, 31008, Pamplona, Navarra, Spain; CIBERONC, ISC-III, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2019.03.013DOI Listing
July 2019

SURVIVAL AND PERIOPERATIVE MORBIDITY OF TOTALLY LAPAROSCOPIC VERSUS OPEN GASTRECTOMY FOR EARLY GASTRIC CANCER: ANALYSIS FROM A SINGLE LATIN AMERICAN CENTRE.

Arq Bras Cir Dig 2019 Jan 7;32(1):e1413. Epub 2019 Jan 7.

Esophagogastric Surgery Unit, Digestive Surgery Department, Hospital Dr. Sotero del Rio, Pontificia Universidad Católica de Chile, Santiago, Chile.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1590/0102-672020180001e1413DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323630PMC
January 2019

Cytology Smears in the Era of Molecular Biomarkers in Non-Small Cell Lung Cancer: Doing More With Less.

Arch Pathol Lab Med 2018 Mar;142(3):291-298

From the Department of Pathology, Clínica Universidad de Navarra, (Drs Lozano, Echeveste, Abengozar, Mejías, Idoate, and de Andrea), IDISNA and Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA) (Dr Calvo), and the Department of Histology and Pathology (Drs Calvo and de Andrea), University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0208-RADOI Listing
March 2018

miR-146a targets c-met and abolishes colorectal cancer liver metastasis.

Cancer Lett 2018 02 11;414:257-267. Epub 2017 Nov 11.

IDISNA and Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Navarra, Spain; Department of Histology and Pathology, University of Navarra, Pamplona, Spain; CIBERONC, ISC-III, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2017.11.008DOI Listing
February 2018

Translating cancer epigenomics into the clinic: focus on lung cancer.

Transl Res 2017 11 2;189:76-92. Epub 2017 Jun 2.

Biomarkers and Precision Medicine Unit. Health Research Institute La Fe, Valencia, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trsl.2017.05.008DOI Listing
November 2017

Role of TGF-β in metastatic colon cancer: it is finally time for targeted therapy.

Cell Tissue Res 2017 10 30;370(1):29-39. Epub 2017 May 30.

CIBERONC, IDISNA, and Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, 31008, Pamplona, Navarra, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00441-017-2633-9DOI Listing
October 2017

Development of biological tools to assess the role of TMPRSS4 and identification of novel tumor types with high expression of this prometastatic protein.

Histol Histopathol 2017 Sep 20;32(9):929-940. Epub 2016 Dec 20.

IDISNA and Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Navarra, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14670/HH-11-857DOI Listing
September 2017

The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche.

Cancer Lett 2017 08 24;402:43-51. Epub 2017 May 24.

Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain; Program of Solid Tumors and Biomarkers, Center for Applied Medical Research, Pamplona, Spain; Health Research Institute of Navarra (IDISNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2017.05.012DOI Listing
August 2017

The challenge of targeting cancer stem cells to halt metastasis.

Semin Cancer Biol 2017 06 18;44:25-42. Epub 2017 Mar 18.

Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, 123 Old Brompton Road, London, SW7 3RP, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2017.03.003DOI Listing
June 2017

TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients.

Cancer Lett 2016 Jan 4;370(2):165-76. Epub 2015 Nov 4.

Department of Histology and Pathology, School of Medicine, University of Navarra, C/Irunlarrea 1, 31008 Pamplona, Spain; Program of Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2015.10.012DOI Listing
January 2016

Leishmanicidal activities of novel methylseleno-imidocarbamates.

Antimicrob Agents Chemother 2015 Sep 6;59(9):5705-13. Epub 2015 Jul 6.

Instituto de Salud Tropical (ISTUN), University of Navarra, Pamplona, Spain Department of Microbiology and Parasitology, University of Navarra, IdiSNA, Navarra Institute for Health Research, Pamplona, Spain

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.00997-15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538474PMC
September 2015

Sphere-derived tumor cells exhibit impaired metastasis by a host-mediated quiescent phenotype.

Oncotarget 2015 Sep;6(29):27288-303

Program in Solid Tumors and Biomarkers, Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.4803DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694990PMC
September 2015

Sunitinib reduces tumor hypoxia and angiogenesis, and radiosensitizes prostate cancer stem-like cells.

Prostate 2015 Aug 20;75(11):1137-49. Epub 2015 Apr 20.

Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.22980DOI Listing
August 2015

Co-migration of colon cancer cells and CAFs induced by TGFβ₁ enhances liver metastasis.

Cell Tissue Res 2015 Mar 6;359(3):829-39. Epub 2015 Jan 6.

Division of Oncology, CIMA, University of Navarra, Pio XII, 55, 31008, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00441-014-2075-6DOI Listing
March 2015

The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties.

Cancer Lett 2015 Jan 6;356(2 Pt B):899-909. Epub 2014 Nov 6.

Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; Department of Histology and Pathology, University of Navarra, Pamplona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2014.10.035DOI Listing
January 2015

Metastatic dormancy: a complex network between cancer stem cells and their microenvironment.

Histol Histopathol 2014 Dec 2;29(12):1499-510. Epub 2014 Jun 2.

Division of Oncology, Center for Applied Medical Research (CIMA), and Department of Histology and Pathology, School of Medicine, University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14670/HH-29.1499DOI Listing
December 2014

Differential effects of drugs targeting cancer stem cell (CSC) and non-CSC populations on lung primary tumors and metastasis.

PLoS One 2013 20;8(11):e79798. Epub 2013 Nov 20.

Laboratory of Novel Therapeutic Targets, Division of Oncology, CIMA of the University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0079798PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835894PMC
September 2014

Differential tumor expression of inhibitor of differentiation-1 in prostate cancer patients with extreme clinical phenotypes and prognostic implications.

Clin Genitourin Cancer 2014 Apr 12;12(2):87-93. Epub 2013 Oct 12.

Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain; Division of Oncology, Center for Applied Medical Research (CIMA), Pamplona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2013.08.007DOI Listing
April 2014

Synthesis and antiproliferative activity of novel selenoester derivatives.

Eur J Med Chem 2014 Feb 12;73:153-66. Epub 2013 Dec 12.

Synthesis Section, Department of Organic and Pharmaceutical Chemistry, University of Navarra, Irunlarrea 1, E-31008 Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmech.2013.11.034DOI Listing
February 2014

Simultaneous phenotypic and genetic characterization of single circulating tumor cells from colon cancer patients.

Histol Histopathol 2013 11 8;28(11):1439-50. Epub 2013 May 8.

Immunology Division, Department of Health Sciences, Faculty of Experimental Sciences, University of Jaén, Jaén, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14670/HH-28.1439DOI Listing
November 2013

Spatial-temporal protein expression of inhibitor of differentiation-1 (Id1) during fetal embryogenesis and in different mouse and human cancer types.

Histol Histopathol 2013 08 5;28(8):1029-40. Epub 2013 Apr 5.

Oncology Division, Center for Applied Medical Research, CIMA, University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14670/HH-28.1029DOI Listing
August 2013

[Gastric lipoma removed by laparoscopic subtotal gastrectomy: report of one case].

Rev Med Chil 2013 Jul;141(7):927-31

Departamento de Cirugía Digestiva, Servicio de Cirugía, Servicio de Salud Metropolitano Sur Oriente, Hospital Sótero del Río, Santiago, Chile.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4067/S0034-98872013000700014DOI Listing
July 2013

Inactivation of encapsulated cells and their therapeutic effects by means of TGL triple-fusion reporter/biosafety gene.

Biomaterials 2013 Jan 19;34(4):1442-51. Epub 2012 Nov 19.

NanoBioCel Group, Laboratory of Pharmaceutics, University of the Basque Country, School of Pharmacy, Vitoria, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biomaterials.2012.10.076DOI Listing
January 2013

Structure- and cell-specific effects of imidoselenocarbamates on selenoprotein expression and activity in liver cells in culture.

Metallomics 2012 Dec;4(12):1297-307

Synthesis Section, Department of Organic and Pharmaceutical Chemistry, University of Navarra, Irunlarrea, 1, E-31008 Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c2mt20096aDOI Listing
December 2012

Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention.

Expert Opin Investig Drugs 2012 Aug 6;21(8):1107-22. Epub 2012 Jun 6.

Department of Lung Development and Remodeling, Molecular Mechanisms in Lung Cancer, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2012.693478DOI Listing
August 2012

Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer.

Mol Cancer 2011 Aug 9;10:96. Epub 2011 Aug 9.

Laboratory of Novel Therapeutic Targets, Oncology Division, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-4598-10-96DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199900PMC
August 2011

[Results of pancreaticoduodenectomy in the treatment of periampullary tumors].

Rev Med Chil 2011 Aug 20;139(8):1015-24. Epub 2011 Dec 20.

Cirugía Digestiva, Servicio de Cirugía, Hospital Sótero del Río, Chile.

View Article

Download full-text PDF

Source
http://dx.doi.org//S0034-98872011000800006DOI Listing
August 2011

Novel library of selenocompounds as kinase modulators.

Molecules 2011 Jul 27;16(8):6349-64. Epub 2011 Jul 27.

Department of Organic and Pharmaceutical Chemistry, University of Navarra, Irunlarrea, Pamplona E-31008, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/molecules16086349DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264252PMC
July 2011

Selenoprotein-P is down-regulated in prostate cancer, which results in lack of protection against oxidative damage.

Prostate 2011 Jun 17;71(8):824-34. Epub 2010 Nov 17.

Division of Oncology, Center for Applied Medical Research, Department of Histology and Pathology, University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.21298DOI Listing
June 2011

Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance.

Clin Cancer Res 2011 Jun 3;17(12):4155-66. Epub 2011 May 3.

Departments of Oncology, Pathology, and Thoracic Surgery, Clínica Universidad de Navarra; Division of Oncology, Center for Applied Medical Research (CIMA), Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-3381DOI Listing
June 2011

PDGFR signaling blockade in marrow stroma impairs lung cancer bone metastasis.

Cancer Res 2011 Jan 19;71(1):164-74. Epub 2010 Nov 19.

Novel Therapeutics Targets, Division of Oncology, Center for Applied Biomedical Research (CIMA), University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-1708DOI Listing
January 2011

Synthesis and antiproliferative activity of novel symmetrical alkylthio- and alkylseleno-imidocarbamates.

Eur J Med Chem 2011 Jan 27;46(1):265-74. Epub 2010 Nov 27.

Synthesis Section, Department of Organic and Pharmaceutical Chemistry, University of Navarra, Irunlarrea, 1, E-31008 Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmech.2010.11.013DOI Listing
January 2011

Tyrosine kinase inhibitors with antiangiogenic properties for the treatment of non-small cell lung cancer.

Expert Opin Investig Drugs 2011 Jan 11;20(1):61-74. Epub 2010 Dec 11.

Center for Applied Medical Research (CIMA), Division of Oncology, University of Navarra, Pamplona, 31008, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2011.541153DOI Listing
January 2011

Use of a combination of biomarkers in serum and urine to improve detection of prostate cancer.

World J Urol 2010 Dec 15;28(6):681-6. Epub 2010 Jul 15.

Laboratory of Novel Therapeutic Targets, Division of Oncology, CIMA, University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-010-0583-xDOI Listing
December 2010

VEGF₁₂₁b and VEGF₁₆₅b are weakly angiogenic isoforms of VEGF-A.

Mol Cancer 2010 Dec 31;9:320. Epub 2010 Dec 31.

Laboratory of Novel Therapeutic Targets, Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://molecular-cancer.biomedcentral.com/articles/10.1186/1
Publisher Site
http://dx.doi.org/10.1186/1476-4598-9-320DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022671PMC
December 2010

Evidence that genetic variants of metabolic detoxication and cell cycle control are not related to gallbladder cancer risk in Chilean women.

Int J Biol Markers 2010 Apr-Jun;25(2):75-8

Department of Community Preventive Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

View Article

Download full-text PDF

Source
September 2010

Improvement of the monitoring and biosafety of encapsulated cells using the SFGNESTGL triple reporter system.

J Control Release 2010 Aug 23;146(1):93-8. Epub 2010 May 23.

Laboratory of Novel Therapeutic Targets, Centre for Applied Biomedical Research (CIMA), University of Navarra, Avenida Pio XII 55, 31007 Pamplona, Spain.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016836591000386
Publisher Site
http://dx.doi.org/10.1016/j.jconrel.2010.05.018DOI Listing
August 2010

VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop.

Exp Cell Res 2010 Feb 16;316(4):554-67. Epub 2009 Dec 16.

Laboratory of Novel Therapeutic Targets, Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Avda. Pio XII, 55, 31008 Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2009.11.020DOI Listing
February 2010

Genetic variants involved in gallstone formation and capsaicin metabolism, and the risk of gallbladder cancer in Chilean women.

World J Gastroenterol 2010 Jan;16(3):372-8

Division of Social and Environmental Medicine, Department of Community Preventive Medicine, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2807960PMC
http://dx.doi.org/10.3748/wjg.v16.i3.372DOI Listing
January 2010

Synthesis and pharmacological screening of several aroyl and heteroaroyl selenylacetic acid derivatives as cytotoxic and antiproliferative agents.

Molecules 2009 Sep 1;14(9):3313-38. Epub 2009 Sep 1.

Synthesis Section, Department of Organic and Pharmaceutical Chemistry, University of Navarra, Irunlarrea, 1, E-31008 Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/molecules14093313DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254723PMC
September 2009

Human adrenomedullin up-regulates interleukin-13 receptor alpha2 chain in prostate cancer in vitro and in vivo: a novel approach to sensitize prostate cancer to anticancer therapy.

Cancer Res 2008 Nov;68(22):9311-7

Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-2810DOI Listing
November 2008

Phenotypic and genetic characterization of circulating tumor cells by combining immunomagnetic selection and FICTION techniques.

J Histochem Cytochem 2008 Jul 14;56(7):667-75. Epub 2008 Apr 14.

Immunology Division, Department of Health Sciences, Faculty of Experimental Sciences, Campus las Lagunillas, University of Jaén, 23071 Jaén, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1369/jhc.2008.951111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430160PMC
July 2008

Novel potent organoselenium compounds as cytotoxic agents in prostate cancer cells.

Bioorg Med Chem Lett 2007 Dec 17;17(24):6853-9. Epub 2007 Oct 17.

Sección de Síntesis, Departamento de Química Orgánica y Farmacéutica, University of Navarra, Irunlarrea, 1, E-31008 Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2007.10.022DOI Listing
December 2007

Methylseleninic acid enhances the effect of etoposide to inhibit prostate cancer growth in vivo.

Int J Cancer 2007 Sep;121(6):1197-204

Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.22764DOI Listing
September 2007

Increased expression of VEGF121/VEGF165-189 ratio results in a significant enhancement of human prostate tumor angiogenesis.

Int J Cancer 2007 May;120(10):2096-109

Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pio XII 55, 31008 Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.22461DOI Listing
May 2007

Alternative splicing: an emerging topic in molecular and clinical oncology.

Lancet Oncol 2007 Apr;8(4):349-57

Oncology Division, Centre for Applied Medical Research, School of Medicine, University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(07)70104-3DOI Listing
April 2007

2-methoxyestradiol induces mammary gland differentiation through amphiregulin-epithelial growth factor receptor-mediated signaling: molecular distinctions from the mammary gland of pregnant mice.

Endocrinology 2007 Mar 7;148(3):1266-77. Epub 2006 Dec 7.

Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, National Institutes of Health, Building 41, 41 Medlars Drive, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/en.2006-0964DOI Listing
March 2007

Free fatty acid concentrations in gallbladder bile collected from Chilean patients with gallstones.

Clin Biochem 2006 Apr 20;39(4):410-3. Epub 2005 Dec 20.

Division of Social and Environmental Medicine, Department of Community Preventive Medicine, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Niigata 951-8510, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinbiochem.2005.11.006DOI Listing
April 2006

Distinct tumor stage-specific inhibitory effects of 2-methoxyestradiol in a breast cancer mouse model associated with Id-1 expression.

Cancer Res 2006 Apr;66(7):3495-503

Laboratory of Cell Regulation and Carcinogenesis, Building 41, National Cancer Institute/NIH, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-2372DOI Listing
April 2006

Adrenomedullin prevents apoptosis in prostate cancer cells.

Regul Pept 2006 Jan 17;133(1-3):115-22. Epub 2005 Nov 17.

Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.regpep.2005.09.026DOI Listing
January 2006

Prostate cancer and the genomic revolution: Advances using microarray analyses.

Mutat Res 2005 Aug;576(1-2):66-79

Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, NIH, Building 41, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mrfmmm.2004.08.019DOI Listing
August 2005

Gene expression profiling identifies IL-13 receptor alpha 2 chain as a therapeutic target in prostate tumor cells overexpressing adrenomedullin.

Int J Cancer 2005 May;114(6):870-8

Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.20789DOI Listing
May 2005

Characterization of corpora amylacea glycoconjugates in normal and hyperplastic glands of human prostate.

J Mol Histol 2005 May;36(4):235-42

Department of Cellular Biology, Medical School, Aging Institute, University of Murcia, Espinardo, 30100 Murcia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10735-005-5784-zDOI Listing
May 2005

Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.

Oncogene 2005 Jan;24(5):790-800

Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1208221DOI Listing
January 2005

Application of gene expression profiling for validating models of human breast cancer.

Toxicol Pathol 2004 Mar-Apr;32 Suppl 1:84-9

Transgenic Oncogenesis Group, Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1080/01926230490424897
Publisher Site
http://dx.doi.org/10.1080/01926230490424897DOI Listing
October 2004

Adrenomedullin inhibits prostate cancer cell proliferation through a cAMP-independent autocrine mechanism.

Biochem Biophys Res Commun 2004 Sep;322(3):878-86

Division of Oncology, Center for Applied Medical Research (CIMA), and Department of Histology and Pathology, University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2004.08.006DOI Listing
September 2004

Histochemical study of glycoconjugates in active and photoperiodically-regressed testis of hamster (Mesocricetus auratus).

Acta Histochem 2003 ;105(2):165-73

Department of Cellular Biology, Section of Histology and General Embryology, Medical School, University of Murcia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1078/0065-1281-00701DOI Listing
February 2004

Mitochondrial DNA mutation at the D310 (displacement loop) mononucleotide sequence in the pathogenesis of gallbladder carcinoma.

Clin Cancer Res 2004 Feb;10(3):1041-6

Department of Anatomic Pathology, Pontificia Universidad Catolica de Chile, Hospital Dr. Sotero del Rio, Santiago, Chile.

View Article

Download full-text PDF

Source
February 2004

Genomic approaches to understanding mammary tumor progression in transgenic mice and responses to therapy.

Clin Cancer Res 2004 Jan;10(1 Pt 2):385S-90S

Transgenic Oncogenesis Group, Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
January 2004

The diffuse endocrine system: from embryogenesis to carcinogenesis.

Prog Histochem Cytochem 2003 ;38(2):155-272

Department of Histology and Pathology, Schools of Science and Medicine, University of Navarra, 31080 Pamplona, Spain.

View Article

Download full-text PDF

Source
December 2003

Overexpression of adrenomedullin gene markedly inhibits proliferation of PC3 prostate cancer cells in vitro and in vivo.

Mol Cell Endocrinol 2003 Jan;199(1-2):179-87

Department of Urology, Northwestern University Medical School, Tarry 11-715, 303 E. Chicago Ave., Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0303-7207(02)00229-0DOI Listing
January 2003

Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.

Int J Cancer 2002 Sep;101(3):224-34

Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, NIH, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.10589DOI Listing
September 2002

Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.

Cancer Res 2002 Sep;62(18):5325-35

Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute/NIH, Building 41, Room C629, 41 Library Drive, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
September 2002

Molecular profiling of angiogenesis markers.

Am J Pathol 2002 Jul;161(1):35-41

Department of Ophthalmology, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1850687PMC
http://dx.doi.org/10.1016/S0002-9440(10)64154-5DOI Listing
July 2002

Adenovirus-mediated endostatin delivery results in inhibition of mammary gland tumor growth in C3(1)/SV40 T-antigen transgenic mice.

Cancer Res 2002 Jul;62(14):3934-8

Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
July 2002

Adrenomedullin and proadrenomedullin N-terminal 20 peptide in the normal prostate and in prostate carcinoma.

Microsc Res Tech 2002 Apr;57(2):98-104

Department of Histology and Pathology, University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jemt.10056DOI Listing
April 2002